QUANTRX BIOMEDICAL CORPORATION: 10-Q filed 2013-11-19
What QUANTRX BIOMEDICAL CORPORATION reported in its quarterly report filed 2013-11-19 (fiscal Q3 2013): 30 published measures, 75 facts as tagged in accession 0001415889-13-002381.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-19
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001415889-13-002381 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All QUANTRX BIOMEDICAL CORPORATION filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 428,685 | USD | |
| At 2012-12-31 | 474,027 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 970,665 | USD | |
| At 2012-12-31 | 853,566 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -541,980 | USD | |
| At 2012-12-31 | -379,539 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,467 | USD | |
| At 2012-12-31 | 9,989 | USD | |
| At 2012-09-30 | 19,235 | USD | |
| At 2011-12-31 | 7,565 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -61,747 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -201,441 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -570,076 | USD | 274 |
| 2012-04-01 to 2012-06-30 | -162,817 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -122,522 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -157,855 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 50,000 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -5,475 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -49,522,972 | USD | |
| At 2012-12-31 | -49,321,531 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 3,559 | USD | |
| At 2012-12-31 | 4,380 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 30,000 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -48,759 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -184,133 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -481,711 | USD | 274 |
| 2012-04-01 to 2012-06-30 | -157,428 | USD | 91 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 155,504 | USD | |
| At 2012-12-31 | 237,666 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 12,988 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 44,951 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 17,281 | USD | 274 |
| 2012-04-01 to 2012-06-30 | 8,275 | USD | 91 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 926,665 | USD | |
| At 2012-12-31 | 809,566 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 375,765 | USD | |
| At 2012-12-31 | 375,040 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 39,622 | USD | |
| At 2012-12-31 | 31,981 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 337 | USD | |
| At 2012-12-31 | 2,334 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 2,076 | USD | |
| At 2012-12-31 | 2,564 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 13,744 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 84,656 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 82,271 | USD | 274 |
| 2012-04-01 to 2012-06-30 | 12,129 | USD | 91 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 20,083 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 23,294 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 21,266 | USD | 274 |
| 2012-04-01 to 2012-06-30 | 14,126 | USD | 91 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 52,528,644 | shares | |
| At 2012-12-31 | 52,528,644 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 48,130,044 | USD | |
| At 2012-12-31 | 48,130,044 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -29,947 | USD | |
| At 2012-12-31 | -29,127 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 39,622 | USD | |
| At 2012-12-31 | 31,981 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 25,361 | USD | |
| At 2012-12-31 | 16,978 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -61,747 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -201,441 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -570,076 | USD | 274 |
| 2012-04-01 to 2012-06-30 | -162,817 | USD | 91 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 273 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 821 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 14,124 | USD | 274 |
| 2012-04-01 to 2012-06-30 | 4,097 | USD | 91 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 1,997 | USD | 273 |
| 2012-01-01 to 2012-09-30 | -1,708 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 488 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 320 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -7,124 | USD | 273 |
| 2012-01-01 to 2012-09-30 | 82,942 | USD | 274 |
Inspect the source
- Entity
- QUANTRX BIOMEDICAL CORPORATION / CIK 0000820608
- Captured
- SEC response SHA-256
9ed677f1f65a020d7443764a5b8258c716645c1ae82e75ef1907f7558ecaa289
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000820608.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))